SUBSCRIBE
SUBSCRIBE

Press Releases

Browse the the latest press releases from around the industry. Want to filter press releases by date, keyword, and more? Search here.

THE LATEST
Press Releases
Biolexis Therapeutics to Present at J.P. Morgan Healthcare Conference
Company to Highlight the complete solution to the GLP-1 weight regain crisis: Only All-Oral Dual-Mechanism Metabolic Platform in Clinical Development, Featuring First-in-Class Oral GLP-1 Agonist and Muscle-Selective AMPK Activator
January 9, 2026
 · 
1 min read
Press Releases
Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2025 Net Revenue
January 9, 2026
 · 
10 min read
Press Releases
Clene Announces Registered Direct Offering of Over $28 Million
January 9, 2026
 · 
10 min read
Press Releases
Lexicon Pharmaceuticals Publishes “Relief is Possible: Ensuring Access to Effective Treatments for Chronic Pain”
January 9, 2026
 · 
3 min read
Press Releases
CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 9, 2026
 · 
1 min read
Press Releases
Tenaya Therapeutics Announces 2026 Strategic Priorities and Anticipated Milestones
January 9, 2026
 · 
11 min read
Press Releases
CG Oncology Provides Updated Timeline for PIVOT-006 Phase 3 Topline Data in Intermediate-Risk NMIBC
January 9, 2026
 · 
5 min read
Press Releases
Autonomix Showcases Compelling PoC Study Clinical Data Showing Rapid and Durable Pain Relief Across All Disease Stages of Pancreatic Cancer at the 2026 ASCO Gastrointestinal (GI) Cancers Symposium
January 9, 2026
 · 
5 min read
Press Releases
PDS Biotech Announces FDA Alignment on use of Progression Free Survival (PFS) as Primary Endpoint
January 9, 2026
 · 
6 min read
Press Releases
Senti Bio to Participate in Panel Presentation at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference
January 9, 2026
 · 
3 min read
Press Releases
MEDIPOST Inc. Announces $140 Million in Funding to Accelerate Late-Stage Clinical Development
January 9, 2026
 · 
2 min read
Press Releases
Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models
January 9, 2026
 · 
3 min read
Press Releases
Orca Bio Announces $250M in Aggregate Financing in Preparation for Potential Commercialization
January 9, 2026
 · 
3 min read
Press Releases
Naveris® to Highlight New Publications at the 44th Annual J.P. Morgan Healthcare Conference
January 9, 2026
 · 
2 min read
Press Releases
AirNexis Therapeutics Launches with $200M Series A to Advance Phase 2 Dual PDE3/4 Inhibitor AN01 for Chronic Obstructive Pulmonary Disease (COPD)
January 9, 2026
 · 
2 min read
Press Releases
Mammoth Biosciences to Present at 44th Annual J.P. Morgan Healthcare Conference
January 9, 2026
 · 
1 min read
Press Releases
Curis Announces Closing of Private Placement Totaling up to $80.8 Million in Gross Proceeds
January 9, 2026
 · 
1 min read
Press Releases
Averna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 9, 2026
 · 
1 min read
Press Releases
Curiteva Announces First Clinical Use of Inspire Standalone ALIF System
January 9, 2026
 · 
2 min read
Press Releases
Aptevo Therapeutics Secures $60 Million Equity Line of Credit to Support Multispecific Portfolio Advancement, Increase Strategic Optionality
January 9, 2026
 · 
8 min read
Press Releases
Rhythm Pharmaceuticals Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Product Revenues and Upcoming Milestones
January 9, 2026
 · 
11 min read
Press Releases
Flare Therapeutics Appoints Stephen L. Eck, M.D., Ph.D., as Chief Medical Officer
January 9, 2026
 · 
4 min read
Press Releases
Elutia to Present at Global BioInnovation Forum on NXT-41x Biomatrix Program for Plastic and Reconstructive Surgery
January 9, 2026
 · 
5 min read
Press Releases
NewAmsterdam Pharma Highlights 2025 Achievements and Outlines 2026 Strategic Priorities
January 9, 2026
 · 
14 min read
Press Releases
InnoCare Announces Approval of Phase II/III Clinical Trial of Novel TYK2 Inhibitor Soficitinib for Chronic Spontaneous Urticaria in China
December 18, 2025
 · 
2 min read
Press Releases
U.S. FDA Approval of RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) Enables the Simplest, Shortest Administration Time for a First-Line Combination Regimen when Combined with LAZCLUZE® (lazertinib)
December 18, 2025
 · 
33 min read
Press Releases
Nature | Two Phase 3 Clinical Results of Mazdutide (GLP-1/GCG Dual Receptor Agonist) in Chinese Adults with Type 2 Diabetes Have Been Back-to-Back Published in Nature
December 18, 2025
 · 
15 min read
Press Releases
Sapu BioScience Highlights TGFB2-Guided Strategy to Enhance Taxane Therapies, Reinforcing the Rationale for Sapu-001
December 18, 2025
 · 
2 min read
Press Releases
Eilean Therapeutics Advances ZE74-0282, a Highly Selective Inhibitor of Mutated JAK2 V617F, into First-in-Human Clinical Development
December 18, 2025
 · 
4 min read
Press Releases
Clywedog Therapeutics Announces Activation of All Centers and Patient Dosing in Multicenter, International Phase 1b Clinical Study of Balomenib in Type 2 Diabetes
December 18, 2025
 · 
3 min read
Press Releases
Inventiva to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 18, 2025
 · 
1 min read
Press Releases
Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
December 18, 2025
 · 
14 min read
Press Releases
Sutro Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
December 18, 2025
 · 
3 min read
Press Releases
Immuneering Advances Towards Dosing First Patient in Phase 3 Atebimetinib Trial for First-Line Metastatic Pancreatic Cancer Patients, Securing Alignment with FDA and EMA
December 18, 2025
 · 
6 min read
Load More